Senior insider sale
CAAO and PAO at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$1.45M
47.15K shares
GILLIS JONATHAN plans to sell 47.15K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $1.45M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/17/2026 | Restricted Stock Unit Grant N/A | 277.00 | — |
10/26/2025 | Restricted Stock Unit Grant N/A | 7.64K | — |
7/18/2024 | Restricted Stock Unit Grant N/A | 6.36K | — |
5/2/2024 | Restricted Stock Unit Grant N/A | 3.69K | — |
11/9/2023 | Restricted Stock Unit Grant N/A | 1.27K | — |
7/30/2023 | Restricted Stock Unit Grant N/A | 2.34K | — |
| Total | 21.58K | ||
Completed
Units to sell
900.00
Market value
$34.4K
Units to sell
600.00
Market value
$21.9K
Units to sell
16.97K
Market value
$638.2K
Units to sell
6.98K
Market value
$255.9K
Units to sell
1.48K
Market value
$55.3K
Units to sell
5.36K
Market value
$193.5K
Units to sell
4.70K
Market value
$173.6K
Planned — Approximate Date
Units to sell
10.17K
Market value
$79.4K
Units
47.15K
Value
$1.45M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/17/2026 | 900.00 | $34.4K | — | Completed |
7/17/2026 | 600.00 | $21.9K | — | Completed |
7/17/2026 | 16.97K | $638.2K | — | Completed |
7/16/2026 | 6.98K | $255.9K | — | Completed |
7/16/2026 | 1.48K | $55.3K | — | Completed |
7/15/2026 | 5.36K | $193.5K | — | Completed |
7/15/2026 | 4.70K | $173.6K | — | Completed |
| Planned — Approximate Date | ||||
10/15/2026 | 10.17K | $79.4K | NASDAQ | Planned |
| Total | 47.15K | $1.45M | ||